文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > anakinra

anakinra

  • Addressing the safety of anakinra in patients with rheumatoid arthritis

    ...i:10.1093/rheumatology/keg330,availableonlineatwww.rheumatology.oupjournals.orgAddressingthesafetyofanakinrainpatientswithrheumatoidarthritisR.M.FleischmannAnakinra(Kineret®;AmgenInc.,ThousandOaks,CA)ist...

  • Treatment of RA With anakinra a rhI-1Ra in Combination With Methotrexate

    ...14–624DOI10.1002/art.10141©2002,AmericanCollegeofRheumatologyTreatmentofRheumatoidArthritisWithAnakinra,aRecombinantHumanInterleukin-1ReceptorAntagonist,inCombinationWithMethotrexateResultsofaTwenty-Four...

  • Addressing the safety of anakinra in patients with rheumatoid arthritis

    ...i:10.1093/rheumatology/keg330,availableonlineatwww.rheumatology.oupjournals.orgAddressingthesafetyofanakinrainpatientswithrheumatoidarthritisR.M.FleischmannAnakinra(Kineret®;AmgenInc.,ThousandOaks,CA)ist...

  • Efficacy of abatacept in a refractory case of adult-onset Still’s disease

    ...y refractory such as anti-TNFs rheumatic and IL-cases of AOSD and provided important clues However, anakinra and anti-TNFs may for its pathophysiology (5-8). also fail in AOSD due to inef cacy or side effects...

  • 类风湿关节炎治疗RA的常用生物制剂

    ... 罕见脱髓鞘反应阿那白滞素 IL-1受体拮 皮下注射:100~150mg,每天 12周之内起效 痛,眩晕,恶心 Anakinra 抗剂 一次 可持续至24周 罕见超敏反应 (kineret)利妥昔单抗 抗人CD20 ...

  • 生物制剂在风湿病的应用

    133 专家笔谈 生物制剂在风湿病的应用顾越英 叶霜  生物制剂是针对特定致病性靶分子的拮抗物,以期靶向性地阻断疾病的发生和发展进程;区别于传统的小分子化合物药物,生物制剂是通过生物工程方法制造的生物大分子。近十年来,生物制剂在以类风湿关节炎(rheumatoidarthritis,RA)为代表的风湿病中的应用取得了重大突破,在风湿病治疗进展中具有里程碑的意义。一、生物制剂的分类和种类目前在风...

  • 类风湿关节炎治疗药物的分子作用机制研究进展

    ...F)以及集落刺激因子、干扰素等。细胞因子种类繁多,其生物学活性复杂多样,作为消炎免疫药物治疗RA的作用机制同样也是多方面的。1.1IL-1阻断剂通过阻断IL-1的生物学功能而发挥作用的Kineret(Anakinra)为Amgen公司的产品,美国FDA于2001年批准其上市,为首个重组的选择性IL-1阻断剂。IL-1生物学作用非常广泛,是作用最强的炎症介质之一,能介导多种炎症反应,如诱导细胞黏附分子表达、吸引中性...

  • The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance (1)

    ...nsistent with these data, randomized clinical trials have shown that blockade of IL-1B signaling by anakinra, a recombinant human IL-1 receptor antagonist, leads to a sustained reduction in systemic inflammat...

  • A role for the NLRP3 inflammasome in metabolic diseases—did Warburg

    ... pathogenesis of metabolic disorders. Studies have tested the recombinant IL-1 receptor antago-nist anakinra in the treatment of type 2 diabetes with some encour-aging results4. Clinical trials also suggest t...

  • 国外制药公司新药开发研制动态

    国外制药公司新药开发研制动态已有证据表明,Roche公司的脂酶抑制剂orlis—tat(商品名为Xenical)不仅能减轻2型糖尿病病人的体重,降低血脂浓度,而且能明显改善病人的血糖控制。体内的血红蛋白A-。浓度亦有明显降低。另外,当orli—stat与其它抗糖尿病药合用时,还可减少其他药物的用量。因此认为,orlistat确实对2型糖尿病病人有益。对于2型糖尿病病人而言,体重过重是一个极其危险的...

  • Impact of TNF-blocking agents on male sperm characteristics and pregnancy outcomes in fathers expose

    ...-eight pa-ing (twenty-seven with TNF-block-had fathered children during treatment. agents, one with anakinra) who Unfortunately, outcomes vided.of the no pregnancies information was on pro-the A study on the ...

    最近文档搜索:

      站点地图 | 文档上传 | 侵权投诉 | 手机版
      本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
      文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email